Introduction
Platelet activation is a required step in hemostasis following vascular injury. After binding to exposed ligands on the subendothelium, platelets change shape to increase their surface area, become tethered together forming an aggregate, and degranulate releasing a variety of agonists which recruit and activate other platelets. Platelets have been the focus of much study due to multiple hematological abnormalities which have been attributed to defects in these cells. Considerable progress has been made in understanding the biochemical events involved in platelet activation. These studies, coupled with investigations involving human patients and genetically altered mice, have elucidated the molecular basis for several bleeding disorders resulting from mutations within platelet surface receptors or key signaling molecules.
A complete understanding of platelet function is made complicated by the existence of multiple surface receptors capable of initiating platelet activation. These include seven transmembrane domain GTP binding protein coupled receptors (GPCRs), numerous integrins, and members of the immunoglobulin superfamily including the collagen receptor, GPVI (Clemetson et al., 1999; Ezumi et al., 2000; Jandrot-Perrus et al., 2000) , and a negative regulator of platelet activation, PECAM-1 (Patil et al., 2001) . Numerous laboratories have been studying each of these molecules resulting in signi®cant advances toward understanding the machinery underlying platelet activation.
Among the GPCR's on platelets are the receptors for ligands including adenosine, epinephrine, thromboxane, as well as the circulating protease, thrombin (reviewed by Oermanns, 2000) . The receptor for thrombin belongs to a unique class of GPCRs known as protease-activated receptors (PARs) (Coughlin, 2000) . Proteolytic cleavage of the extracellular domain of PARs reveals a new amino-terminus that serves as a tethered peptide-ligand. This tethered ligand binds intramolecularly to the receptor resulting in activation. In recent years, much has been learned about the signaling events resulting from engagement of PARs and other GPCRs found on platelets, the results of which have been reviewed extensively elsewhere (Brass, 2001; Coughlin, 2000) .
Signaling via the collagen and ®brinogen receptors
By binding to exposed subendothelial collagen ®bers, platelets initiate one of the primary steps in clot formation. While many platelet surface receptors have been shown to bind collagen, a2b1 and GPVI are believed by many to be the two most critical for platelet activation (Watson and Gibbins, 1998) . A two site, two step model of collagen-induced platelet activation has been proposed, in which platelets passing near a vascular lesion initially associate with collagen via a high anity interaction of a2b1 with exposed collagen ®bers. Once collagen is bound to the platelet, GPVI is then engaged leading to the signal transduction events necessary for degranulation, shape change, and aggregation (Watson and Gibbins, 1998) . Evidence for the two site model comes from studies conducted with a2b1-blocking antibodies and GPVIspeci®c agonists. In the presence of anti-a2b1, higher concentrations of collagen are required to induce platelet aggregation compared to untreated control platelets (Verkleij et al., 1998) . In addition, GPVIspeci®c ligands (including collagen related peptide (CRP) (Morton et al., 1995) , the snake venom toxin convulxin (Cvx) (Polgar et al., 1997) , and the GPVIspeci®c antibody JAQ-1 (Nieswandt et al., 2000) ) illustrate that direct stimulation of this receptor results in the same signal transduction events characteristic of collagen stimulation. Additionally, patients lacking GPVI (Moroi et al., 1989) , but not other proposed collagen receptors such as CD36 (GPIV) (Yamamoto et al., 1992) , exhibit a bleeding diathesis. A recent report describing mice made de®cient for the b1 integrin has called into question the role of a2b1 in collagen-induced platelet activation as platelets derived from these mice respond to collagen, albeit with decreased kinetics . In contrast, GPVI de®cient platelets fail to respond to either collagen or CRP (Kehrel et al., 1998) , suggesting that this receptor is critical for both hemostasis and platelet function. Collectively, these data suggest that while a2b1 may be important for optimal collagen mediated activation, it is not absolutely required for a functional response.
The recent cloning of GPVI, and its subsequent classi®cation as a member of the immunoglobulin family of receptors (Clemetson et al., 1999; Ezumi et al., 2000; Jandrot-Perrus et al., 2000) , reinforces the notion that signal transduction downstream of collagen receptor(s) in platelets closely parallels that seen following ligation of antigen-receptors on T and B cells. GPVI is a 62 kDa protein with high homology to the Fca receptor found on mast cells (Clemetson et al., 1999) . Even prior to the cloning of GPVI, a noncovalent association of this receptor with the common Fcg subunit was discovered Tsuji et al., 1997) . While it has yet to be determined de®nitively if the cytoplasmic domain of GPVI possesses independent signaling function, the association with Fcg provides GPVI the ability to activate protein tyrosine kinase (PTK) mediated signaling events. This is due to the fact that within the cytoplasmic domain of Fcg is an immunoreceptor tyrosine-based activation motif (ITAM), a conserved sequence composed of tandem YxxL/I (where x is any residue, Y is tyrosine, L is leucine, and I is isoleucine) repeats separated by 6 ± 8 non-conserved amino acids (Reth, 1989) . Engagement of GPVI is believed to result in Src family kinase-mediated phosphorylation of the tyrosines within the ITAM of Fcg (Gibbins et al., 1996) providing an excellent docking site for recruitment and activation of the SH2 domain containing kinase, Syk (Johnson et al., 1995) thus endowing the collagen receptor with PTK activity.
Evidence to support this model of GPVI signaling comes from studies demonstrating co-precipitation of Lyn and Fyn with Fcg (Ezumi et al., 1998 (Poole et al., 1997) . Additionally, mice de®cient for Syk manifest a lethal bleeding diathesis (Kiefer et al., 1998; Turner et al., 1995) demonstrating the requirement for this kinase in hemostasis. Interestingly, while de®ciency in Syk results in a bleeding phenotype, Fcg 7/7 mice show no signs of hemorrhage (Poole et al., 1997) , suggesting that Syk is required for other signaling pathways.
The signal transduction cascade that ensues following GPVI ligation leads to activation of phospholipase Cg2 (PLCg2) (Blake et al., 1994; Daniel et al., 1994) resulting in generation of the second messengers 1,2-diacylglycerol (DAG) and inositol-1,4,5-triphosphate (IP 3 ) (Berridge and Irvine, 1989) . Both second messengers have been associated with platelet responses including shape change, degranulation, and aggregation (Werner et al., 1992) . IP 3 -induces release of calcium from the dense tubular system of platelets increasing the intraplatelet calcium levels from approximately 100 ± 500 nM to the mM levels (Brass and Joseph, 1985) . Chelators of calcium are known to inhibit functional responses to many agonists including CRP. DAG-mediated activation of protein kinase C (PKC) (Murphy et al., 1991) is among the earliest events following agonist stimulation of platelets and has been implicated in both aggregation and secretion (Castagna et al., 1985) .
Platelets express multiple integrins, heterodimeric adhesion receptors for extracellular matrix proteins, on their surface (Ginsberg et al., 1995) . One of the best characterized is aIIbb3, a receptor for ®brinogen. Resting platelets do not bind soluble ®brinogen however, following agonist stimulation`inside-out' signaling events lead to changes in both the anity and avidity of aIIbb3 for its ligand (Shattil, 1999) . Anity modulation of aIIbb3 is thought to mediate an initial, reversible binding of ®brinogen (O'Toole et al., 1991) while avidity modulation (receptor clustering) promotes a stronger association with the ligand (Hato et al., 1998) . Several proteins have been implicated in integrin activation. For example, inhibition of either PKC (Hers et al., 1998) or phosphatidyl inositol 3-kinase (PI3K) (Zhang et al., 1996) blocks agonistinduced aIIbb3 activation. Although the molecular details of inside-out signaling remain unclear, several studies have demonstrated that these events are essential for hemostasis. In this regard, patients with Glanzmann thromasthenia (Tomiyama, 2000) and b3 null mice (Hodivala-Dilke et al., 1999) show that the inability to bind ®brinogen results in a dramatic increase in bleeding time, presumably due to ineective clotting.
Recently it has become clear that, in addition to the initial adhesive function of aIIbb3, engagement of this receptor also initiates`outside-in' signal transduction including activation of the Syk PTK (Gao et al., 1997) , phosphorylation of tyrosine residues within b3 , actin polymerization, and shape change. Tyrosine phosphorylation of b3 appears to be critical for hemostasis, although the precise role of b3 during outside-in signal transduction is not known. Platelets isolated from mice expressing aIIbb3 in which the cytoplasmic tyrosines of b3 are mutated exhibit defective clot retraction and a tendency to rebleed in vivo (Law et al., 1999b) . It remains to be determined if these tyrosines are responsible for the resulting activation of Syk, or if other ITAM-containing molecules are involved.
Studies conducted in platelets and transfected Chinese hamster ovary (CHO) cells indicate that activation of Syk leads to phosphorylation of multiple substrates including the guanine nucleotide exchange factor Vav (Miranti et al., 1998) . Vav in turn activates the Rho family GTPase, Rac (Bustelo, 2000) which has been shown to induce lamellipodia formation (Miranti et al., 1998) . In addition, both Syk and Vav localize to the lamellipodia of CHO cells adherent on ®brinogen (Miranti et al., 1998) . Use of cell line model systems coupled with studies conducted in platelets to identify additional members of this signaling complex will shed light on the mechanisms underlying outside-in signal transduction.
Adapters
The identi®cation and characterization of adapter proteins has provided a link between cell surface receptors and downstream signal transduction cascades. Adapters function as the cellular scaolding upon which signal transduction complexes are assembled. Many adapter molecules lack intrinsic eector function, but contain one or more distinct functional domains that mediate protein ± protein or protein ± lipid interactions. Among the modular domains important for this function are Src homology 2 (SH2) (Schlessinger, 1994) and phosphotyrosine binding (PTB) domains (Forman-Kay and Pawson, 1999) which mediate interactions with phosphorylated tyrosine residues on other proteins, Src homology 3 (SH3) domains, which associate with proline-rich domains (Schlessinger, 1994) , and WW (Sudol, 1996) and PDZ (Bezprozvanny and Maximov, 2001 ) domains which mediate other protein ± protein interactions. Additionally, some adapters mediate protein ± lipid interactions through pleckstrin homology (PH) (Lemmon and Ferguson, 2000) domains.
The founding member of the adapter class is the cytosolic protein, Grb2. Grb2 consists of an SH2 domain¯anked by two SH3 domains (Lowenstein et al., 1992) . The function of this molecule in nucleation of signal transduction downstream of receptor tyrosine kinases has become a paradigm for adapter function. Grb2 associates constitutively with SOS (Olivier et al., 1993) , the guanine nucleotide exchange factor for Ras (Chardin et al., 1993) . Upon ligand binding to growth factor receptors, Grb2 is recruited to phosphorylated tyrosine residues within the cytoplasmic tail of the activated receptor-protein tyrosine kinase (RozakisAdcock et al., 1993) , bringing SOS with it to the plasma membrane. This results in the juxtaposition of the Grb2/SOS complex with membrane-associated Ras resulting in the exchange of GDP for GTP by Ras (Buday and Downward, 1993) . Activated Ras then initiates downstream signals leading ultimately to transcriptional activation of multiple genes.
Since the identi®cation of Grb2, numerous other adapters have been described. Interestingly, many of these molecules are not only important for increasing the eciency of signal transduction and chaperoning eectors in cells, but are absolutely required for cellular function. In this review we will focus on the role of SH2 domain containing leukocyte protein of 76 kDa (SLP-76) (Jackman et al., 1995) an adapter recently shown to play a role in two signal transduction pathways in platelets; collagen-mediated platelet activation and outside-in signaling through integrin aIIbb3 (Judd et al., 2000) .
SLP-76
SLP-76 is a hematopoietic cell-speci®c protein which interacts with other signaling molecules through amino-terminal phosphotyrosine residues (Fang et al., 1996; Wardenburg et al., 1996) , a central proline-rich region, and a carboxyl-terminal SH2 domain (Figure 1 ). Initially, SLP-76 was characterized in T cells where it mediates signal transduction following antigen recognition by the T cell receptor (TCR). Preliminary studies of SLP-76 in the Jurkat T cell line suggested a role for this molecule as a positive regulator. Transient overexpression of SLP-76 in these cells results in an augmentation of signals initiated by the TCR , while loss of SLP-76 results in an uncoupling of the TCR from downstream events such as Erk activation, PLCg1 activation and calcium¯ux (Yablonski et al., 1998) . However, inactivation of any of the three functional domains of SLP-76 results in the inability to augment signals following TCR ligation .
Generation of a SLP-76 de®cient mouse has allowed insight into the functional requirement for this protein in vivo. Mice made de®cient for SLP-76 lack T cells due to a block in thymocyte development presumably caused by a failure of the pre-TCR to transduce signals (Clements et al., 1998; Pivniouk et al., 1998) . In addition to the critical role of SLP-76 in T cells, this adapter is required for hemostasis and platelet function Judd et al., 2000) . SLP-76 7/7 mice exhibit decreased survival characterized by a speci®c loss of a majority of SLP-76 7/7 mice shortly
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Whereas megakaryocytes and platelets develop normally in the absence of SLP-76, platelets from SLP-76 null animals fail to aggregate or degranulate in response to collagen, although they respond to thrombin . Following collagen stimulation of wild-type platelets, multiple substrates of Syk are rapidly phosphorylated including SLP-76 itself Gross et al., 1999) . In SLP-76
cells, Syk is still phosphorylated and activated after platelets are exposed to collagen, however key downstream substrates including PLCg2 fail to become inducibly phosphorylated . Similarly, in collagen stimulated Syk de®cient platelets neither SLP-76 nor PLCg2 (Poole et al., 1997) become inducibly phosphorylated. Surprisingly, while loss of Syk (Kiefer et al., 1998; Turner et al., 1995) , SLP-76 (Clements et al., 1998; Pivniouk et al., 1998) or PLCg2 (Wang et al., 2000) all lead to a bleeding diathesis, Fcg de®cient mice exhibit no signs of bleeding (Poole et al., 1997) . This suggests that defects in the collagen activation pathway alone are not sucient to cause a bleeding phenotype, and that SLP-76, Syk, and PLCg2 play critical roles in addition to mediating collagen signaling in platelet function.
To support this notion, additional studies have revealed that Syk phosphorylates SLP-76 not only following collagen receptor ligation, but also during Figure 1 The SLP-76 signaling complex. The hematopoietic-speci®c adapter protein, SLP-76 is a critical mediator of signal transduction in T cells and platelets. SLP-76 interacts with other signaling molecules through amino-terminal phosphotyrosine residues, a central proline-rich region, and a carboxyl-terminal SH2 domain. As depicted, the inducibly phosphorylated tyrosine residues of SLP-76 mediate associations with the guanine nucleotide exchange factor Vav and the adapter Nck. Formation of this complex is believed to lead to activation of the serine/threonine kinase Pak by the GTP binding protein Rac. Interaction of the Tec family kinase Itk with SLP-76 has been shown to require both the phosphorylated tyrosine residues and the proline rich region of SLP-76. The proline rich region of SLP-76 also binds constitutively to the Grb2 family member Gads, which in turn, associates with phosphorylated tyrosine residues of LAT. This interaction localizes SLP-76 and its associated molecules to specialized regions of the plasma membrane known as glycolipid-enriched membrane microdomains (GEMs) where signal transduction complexes are formed. The constitutively GEM-localized adapter LAT has been shown to associate with PLCg1 in T cells and PLCg2 in platelets. It is thought that by bringing members of the Tec family (such as Itk) to GEMs, SLP-76 facilitates the activation of LAT-associated PLCg. SLAP-130/FYB is another member of the adapter family and was initially identi®ed through its inducible association with the SH2 domain of SLP-76. In addition to binding SKAP-55, SLAP-130/FYB has recently been shown to interact with the actin binding protein VASP. VASP appears to be a negative regulator of platelet function while its role in T cell activation remains uncertain outside-in signaling through aIIbb3 (Figure 2) (Judd et al., 2000; Obergfell et al., 2001) . Consistent with a functional role for SLP-76 in this pathway, platelets from SLP-76 null animals exhibit a marked reduction in spreading and a decrease in whole cell phosphotyrosine levels when adhered to a ®brinogen-coated surface. In vivo reconstitution of SLP-76 by retroviral gene transfer corrects the bleeding diathesis. Additionally, platelets in which SLP-76 expression is reconstituted respond normally to both collagen and ®brinogen (Judd et al., 2000) . Use of retroviral gene transfer of SLP-76 mutants in future experiments will allow further characterization in vivo of the structure/ function relationship of SLP-76 in platelets.
The functional domains of SLP-76

Amino-terminal tyrosines
In T cells, phosphorylation of amino-terminal tyrosine residues of SLP-76 by ZAP-70 is critical for function (Fang et al., 1996; Wardenburg et al., 1996) . These phosphorylated tyrosines mediate interactions with the guanine nucleotide exchange factor Vav, the adapter Nck (Bubeck Wardenburg et al., 1998) , and the Tec family kinase Itk (Bunnell et al., 2000; Schneider et al., 2000; Su et al., 1999) . Each of these associations is felt to be important for optimal SLP-76 function in T cells. Vav is the guanine nucleotide exchange factor for Rac, a member of the Ras superfamily of GTP-binding proteins (Bustelo, 2000) . Upon GTP binding and translocation to the plasma membrane, Rac activates the serine/threonine kinase Pak, which has been implicated in the disassembly of stress ®bers and focal adhesions as well as transcriptional activation of numerous genes (Bagrodia and Cerione, 1999) . The association of SLP-76 with both Nck, which interacts with Pak (Lu, 1997 #27), and Vav is believed to facilitate the activation of Pak (Bubeck Wardenburg et al., 1998) . Binding of Itk to SLP-76 is thought to localize Itk to a larger signaling complex resulting in the phosphorylation and activation of its substrate, PLCg2 (see Figure 1) . The importance of tyrosine phosphorylation of SLP-76 in T cell activation was shown in Jurkat cells as overexpression of a SLP-76 variant in which the three key tyrosine residues are mutated to phenylalanine fails to augment transcrip- Figure 2 The function of SLP-76 in platelets. Mice de®cient for SLP-76 exhibit a bleeding diathesis and platelets from these mice fail to respond to collagen or GPVI-speci®c agonists. In addition, SLP-76 7/7 platelets fail to spread following ®brinogen binding to activated integrin aIIbb3. Collagen activation of platelets is thought to occur through a two-step process in which integrin a2b1 mediates a strong primary interaction with collagen allowing subsequent binding to the immunoglobulin family member GPVI. By association with the ITAM-bearing Fcg chain, GPVI is able to induce activation of the tyrosine kinase Syk leading to phosphorylation of multiple substrates and platelet activation. SLP-76 associates with Gads which inducibly associates with the transmembrane adapter LAT. PLCg2 then becomes activated leading to downstream events such as aggregation and granule secretion. It should be noted, however, that while formation of a LAT/Gads/SLP-76 complex is critical for T cell activation, the role of this complex in platelet activation is less clear. Stimulation of platelets with agonist also leads to inside-out signal transduction to the ®brinogen receptor, integrin aIIbb3. On resting platelets aIIbb3 is unable to bind ®brinogen, but inside-out signaling results in both anity and avidity modulation of this receptor leading to ®brinogen binding. Upon ®brinogen binding, signals transmitted through aIIbb3 result in Syk activation and downstream events including actin polymerization and spreading. SLP-76 plays a critical role in this pathway as well as in collagen-mediated platelet activation
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The interaction of Vav and SLP-76 has been demonstrated in platelets while the interaction with Nck is presumed to occur but has not been shown. The predominant Tec family kinase found in platelets is Btk (Watson and Gibbins, 1998) . Although the exact mechanism through which PLCg2 becomes activated is uncertain, Btk is believed to phosphorylate PLCg2 in platelets as it does in B cells (Fluckiger et al., 1998) . In fact, platelets lacking Btk exhibit a reduction in inducible PLCg2 phosphorylation. Additionally, platelets de®cient for Btk exhibit a partial block in activation in response to both collagen and CRP (Quek et al., 1998) . Other Tec family members present in platelets may be responsible for the residual PLCg2 phosphorylation seen in Btk 7/7 cells. Because SLP-76 is known to associate with a Tec family kinase in T cells, it is possible that there is a direct interaction between Btk and SLP-76 in platelets. Further experiments will be necessary to determine if this interaction exists and to de®ne more precisely the role of SLP-76 in PLCg2 activation in platelets.
The proline-rich region of SLP-76
In vivo, the Grb2 family member Gads (Liu et al., 1999) (also known as GrpL, Grf40 or MONA (Asada et al., 1999; Bourette et al., 1998; Law et al., 1999a) ) associates with SLP-76 through a constitutive interaction of the SH3 domains of Gads and the central proline rich region of SLP-76 (Liu et al., 1999; Asada et al., 1999; Law et al., 1999a) . Upon T cell activation, Gads translocates to the membrane where its SH2 domain associates with phosphorylated tyrosine residues of the membrane-bound Linker for activation of T cells (LAT) (Zhang et al., 1998a) . LAT is a 36 ± 38 kDa adapter which is constitutively localized to specialized regions of the plasma membrane know as glycolipid enriched membrane microdomains (GEMs) (Zhang et al., 1998b) . GEMs serve as the platform upon which signal transduction complexes are formed following receptor ligation. The recruitment of SLP-76 to GEMs through its indirect association with LAT is a critical event during T cell activation. In fact, Jurkat T cells de®cient for either molecule demonstrate an uncoupling of the TCR from downstream events such as calcium¯ux, ERK activation and IL-2 NFAT transcriptional activity (Finco et al., 1998; Yablonski et al., 1998) . Expression of a SLP-76 molecule constitutively targeted to GEMs results in a restoration of these events in both LAT de®cient and SLP-76 de®cient cells (Boerth et al., 2000) .
The existence and importance of GEMs in platelets is an area of current investigation. Initial characterization of platelets from LAT null animals indicated that LAT is required for granule release and activation of aIIbb3 following stimulation with the GPVI-speci®c agonist, CRP. However, whereas SLP-76 fails to be inducibly phosphorylated in LAT de®cient Jurkat cells, it is phosphorylated following CRP stimulation of LAT 7/7 platelets (Pasquet et al., 1999) suggesting that the requirement for LAT may dier in T cells and platelets. While Gads is present in platelets and has been shown to associate with SLP-76 (Asazuma et al., 2000) , the importance of this interaction during platelet activation remains unclear. Further characterization of platelets from Gads 7/7 mice will determine if there is a requirement for this adapter in collagen-mediated platelet activation. It is important to note, however, that in contrast to the requirement for SLP-76 and Syk for hemostasis, neither LAT 7/7 nor Gads 7/7 mice demonstrate a bleeding diathesis although both exhibit defects in T cell development (Yoder et al., 2001; Zhang et al., 1999) . This discrepancy in hemostatic phenotypes between mice which share such similar T cell defects argues further that there is a dierential requirement for these proteins in T cells and platelets.
Interestingly, a recent study conducted with a GPVIblocking antibody indicated that LAT phosphorylation is not necessarily required for collagen mediated platelet aggregation. Based in part on this ®nding, a variation on the model of collagen-mediated receptor activation has been proposed by Schulte et al. (2001) in which two separate collagen binding sites exist within GPVI. According to this model, the antibody JAQ-1 blocks one collagen binding site on GPVI while a second site can be stimulated by high concentrations of collagen. Under such conditions, platelets aggregate and the resulting tyrosine phosphorylation pattern matches that seen with collagen alone, but surprisingly, LAT fails to become phosphorylated . The ability of platelets to aggregate in response to collagen in the absence of LAT phosphorylation argues that the associations mediated by phospho-LAT are not necessary for eective signal transduction via the collagen receptor. Further studies will be required to determine precisely how LAT functions downstream of GPVI.
Because it is clear that defects in collagen-mediated platelet activation alone are not sucient to cause bleeding in mice, it may be that SLP-76, Syk and PLCg2 are required in a platelet activation pathway in which LAT and Gads are not. The absence of a bleeding phenotype in LAT 7/7 mice coupled with the residual phosphorylation of SLP-76 in these platelets, suggests that the inducible interaction between SLP-76 and LAT may not be as critical in platelets as in T cells.
The SH2 domain of SLP-76
The SH2 domain of SLP-76 has been shown to interact with SLP-76 associated phosphoprotein of 130 kDa (SLAP-130) in both T cells (Musci et al., 1997) and platelets . SLAP-130 is also known as Fyn binding protein (Fyb) due to an interaction with this Src family kinase in T cells (da Silva et al., 1997) . It is presumably due to an indirect interaction mediated by SLAP-130/Fyb that the SH2 domain of SLP-76 associates with Fyn and Lyn in platelets . In vitro, an interaction between the Ena/ VASP homology-1 binding domain (EVH1) of SLAP-130/Fyb and the actin-binding protein VASP has been identi®ed (Krause et al., 2000) . Furthermore, SLAP-130/Fyb and VASP associate in activated Jurkat T cells and ®brinogen adherent platelets. Fluorescence microscopy has revealed a colocalization of SLAP-130/FYB and VASP to the periphery of spread platelets (Krause et al., 2000; Obergfell et al., 2001) , a site associated with active actin remodeling. Interestingly, although VASP facilitates actin assembly in vitro,`knockout' studies demonstrate that in the absence of VASP platelets are`hyperactivatable' showing an increased responsiveness to agonists (Aszodi et al., 1999; Hauser et al., 1999) .
One possible mechanism by which VASP may act as a negative regulator is by stabilizing actin ®laments preventing the restructuring of the cytoskeleton required for platelet shape change. Evidence supporting this comes from studies in which VASP was shown to protect actin ®laments from disassembly by gelsolin, an actin ®lament-severing protein, in vitro (Bearer et al., 2000) . The roles of SLP-76 and SLAP-130/Fyb and their relationship to VASP in cytoskeletal reorganization are still being de®ned, however, consistent with a role for SLP-76 in the regulation of actin dynamics in platelets, overexpression of SLP-76 in an aIIbb3 expressing-CHO cell model system leads to increased lamellipodia formation (Obergfell et al., 2001) .
In addition to VASP, SLAP-130/Fyb interacts with the constitutively tyrosine phosphorylated adapter, SKAP-HOM in platelets (Asazuma et al., 2000) . SKAP-HOM is closely related to SKAP-55 (MarieCardine et al., 1998b) , an adapter known to interact with the central proline rich region of SLAP-130/Fyb in T cells (Marie-Cardine et al., 1998a) . SKAP-HOM is ubiquitously expressed (Marie-Cardine et al., 1998b) while SKAP-55 is expressed predominately in T cells (Marie-Cardine et al., 1997) . Both proteins were initially identi®ed through an association with the SH2 domain of Fyn (Marie-Cardine et al., 1997 . Roles for SKAP-55 in T cells and SKAP-HOM in platelets have not yet been de®ned, however, further characterization of both adapters and generation of de®cient mice will provide insight into their functions.
Conclusion
Diculties manipulating platelets and the lack of cell line models have hampered the study of signal transduction in these cells, however, signi®cant advances have been made in recent years. The generation of`knock-out' mice at increasingly rapid rates and the study of patients with platelet disorders has led to important discoveries regarding the molecular machinery underlying platelet activation. Additionally, it is becoming evident that platelets and lymphocytes have adopted a number of similar strategies to regulate signal transduction events following engagement of cell surface receptors. These include the use of ITAM-bearing activating receptors to stimulate similar signal transduction cascades and the use of hematopoietic cell-restricted adapter proteins such as SLP-76 and LAT to integrate these signaling pathways. However, given the unique features of platelets (such as their relatively short life span and inability to transcribe new genes) it is clear also that there are critical dierences in the consequences of signal transduction in platelets and lymphocytes. It is of particular interest, therefore, that while loss of SLP-76 expression results in marked defects in both the T cell and platelet compartment, lack of LAT or Gads expression results in a severe T cell phenotype, but appears not to aect hemostasis.
As noted, there are multiple activating (and inhibitory) receptors on the platelet surface, many of which likely engage their ligands simultaneously. The appropriate response to these environmental cues requires an integration of the various signaling cascades stimulated by the dierent cell surface receptors. One of the most compelling challenges for investigators interested in the biology of platelet signal transduction and activation will be to understand the cross talk between the various second messenger cascades. One important aspect of this cross talk is the creation of multimolecular complexes nucleated by adapter proteins as the temporal and spatial organization of these`signalesomes' is clearly a critical feature of platelet activation. Biochemical techniques amenable to analysing small quantities of proteins and advanced image analysis protocols will be essential for unraveling the complexity of the intermolecular interactions required for eective platelet function.
As genetically altered mice with interesting platelet phenotypes are generated, it becomes increasingly important to develop technologies for reconstitution of the platelet compartment with wild-type or mutant molecules so that rigorous in vivo structure/function analysis can be performed. One approach is to`knockin' alterations in the germ line sequence of a gene as performed by Law et al. (1999b) to investigate the role of key tyrosine residues in the b3 component of the ®brinogen receptor. Alternatively, using megakaryocyte-speci®c promoters transgenic animals are being developed, however identi®cation of a promoter capable of achieving appropriate expression levels has been elusive. A third approach is ex vivo retroviral transduction of bone marrow obtained from`knockout' mice followed by transfer into lethally irradiated recipients. The use of retroviral constructs containing an internal ribosomal entry sequence for co-expression of a reporter gene (such as green¯uorescent protein) along with the gene of interest allows for identi®cation of successfully transduced cells. A direct comparison of reconstituted versus mutant platelets within the same animal can be accomplished using this technique.
It is anticipated that the combination of improved biochemical, imaging, and genetic approaches will result in rapid advances in our understanding of platelet activation over the next few years. It is likely that this new knowledge will be translated quickly into novel approaches for the treatment of functional platelet disorders. Additionally, new insights derived from studies of platelet signal transduction will certainly provide clues to the roles of signal transduction in other cell lineages, both within and beyond the hematopoietic system.
